Search

Adrenic acid (docosatetraenoic acid), an abundant fatty acid in the adrenal gland, is identical to arachidonic acid except for 2 additional carbons on the carboxyl end. Adrenic acid is metabolized by cyclooxygenases, cytochrome P450s, and lipoxygenases; however, little is known regarding the role of adrenic acid and its metabolites in vascular tone. Because of its abundance in the adrenal gland, we investigated the role of adrenic acid in vascular tone of bovine adrenal cortical arteries and its metabolism by bovine adrenal zona glomerulosa cells. In adrenal cortical arteries, adrenic acid caused concentration-dependent relaxations, which were inhibited by the epoxyeicosatrienoic acid antagonist 14,15-epoxyeicosa-5(Z)-enoic acid and the cytochrome P450 inhibitor SKF-525A. The large-conductance calcium-activated potassium channel blocker iberiotoxin or removal of the endothelium abolished these relaxations. Reverse-phase high-pressure liquid chromatography and liquid chromatography/mass spectrometry isolated and identified numerous adrenic acid metabolites from zona glomerulosa cells, including dihomo-epoxyeicosatrienoic acids and dihomo-prostaglandins. In denuded adrenal cortical arteries, adrenic acid caused concentration-dependent relaxations in the presence of zona glomerulosa cells but not in their absence. These relaxations were inhibited by SKF-525A, 14,15-epoxyeicosa-5(Z)-enoic acid, and iberiotoxin. Dihomo-16,17-epoxyeicosatrienoic acid caused concentration-dependent relaxations of adrenal cortical arteries, which were inhibited by 14,15-epoxyeicosa-5(Z)-enoic acid and high potassium. Our results suggest that adrenic acid relaxations of bovine adrenal cortical arteries are mediated by endothelial and zona glomerulosa cell cytochrome P450 metabolites. Thus, adrenic acid metabolites could function as endogenous endothelium-derived and zona glomerulosa-derived hyperpolarizing factors in the adrenal cortex and contribute to the regulation of adrenal blood flow.

All-cis-14,15-epoxyeicosa-5,8,11-trienoic acid (14,15-EET) is a labile, vasodilatory eicosanoid generated from arachidonic acid by cytochrome P450 epoxygenases. A series of robust, partially saturated analogues containing epoxide bioisosteres were synthesized and evaluated for relaxation of precontracted bovine coronary artery rings and for in vitro inhibition of soluble epoxide hydrolase (sEH). Depending upon the bioisostere and its position along the carbon chain, varying levels of vascular relaxation and/or sEH inhibition were observed. For example, oxamide 16 and N-iPr-amide 20 were comparable (ED(50) 1.7 microM) to 14,15-EET as vasorelaxants but were approximately 10-35 times less potent as sEH inhibitors (IC(50) 59 and 19 microM, respectively); unsubstituted urea 12 showed useful activity in both assays (ED(50) 3.5 microM, IC(50) 16 nM). These data reveal differential structural parameters for the two pharmacophores that could assist the development of potent and specific in vivo drug candidates.

Eight members of a recently identified family of tetrahydrofuran-diols (THFDs), originating from epoxyeicosatrienoic acids (EETs), were prepared stereospecifically from D-(+)-glucose. The THFDs potently induced relaxation of pre-contracted bovine arteries.

Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase metabolites of arachidonic acid. EETs mediate numerous biological functions. In coronary arteries, they regulate vascular tone by the activation of smooth muscle large-conductance, calcium-activated potassium (BK(Ca)) channels to cause hyperpolarization and relaxation. We developed a series of 14,15-EET agonists, 14,15-EET-phenyliodosulfonamide (14,15-EET-PISA), 14,15-EET-biotinsulfonamide (14,15-EET-BSA), and 14,15-EET-benzoyldihydrocinnamide-sulfonamide (14,15-EET-BZDC-SA) as tools to characterize 14,15-EET metabolism and binding. Agonist activities of these analogs were characterized in precontraced bovine coronary arterial rings. All three analogs induced concentration-dependent relaxation and were equipotent with 14,15-EET. Relaxations to these analogs were inhibited by the BK(Ca) channel blocker iberiotoxin (100 nM), the 14,15-EET antagonist 14,15-epoxyeicosa-5(Z)-enoylmethylsulfonamide (10 muM), and abolished by 20 mM extracellular K(+). 14,15-EET-PISA is metabolized to 14,15-dihydroxyeicosatrienoyl-PISA by soluble epoxide hydrolase in bovine coronary arteries and U937 cells but not U937 cell membrane fractions. 14,15-EET-P(125)ISA binding to human U937 cell membranes was time-dependent, concentration-dependent, and saturable. The specific binding reached equilibrium by 15 min at 4 degrees C and remained unchanged up to 30 min. The estimated K(d) and B(max) were 148.3 +/- 36.4 nM and 3.3 +/- 0.5 pmol/mg protein, respectively. These data suggest that 14,15-EET-PISA, 14,15-EET-BSA, and 14,15-EET-BZDC-SA are full 14,15-EET agonists. 14,15-EET-P(125)ISA is a new radiolabeled tool to study EET metabolism and binding. Our results also provide preliminary evidence that EETs exert their biological effect through a membrane binding site/receptor.

The photoinduced electron transfer from the excited state of tris(2,2‘-bipyridine)ruthenium(II) (Ru(bpy)32+) incorporated into Nafion membranes to propylviologen sulfonate (PVS°) in the surrounding solution has been examined both by photochemical and photoelectrochemical measurements. N,N‘-Tetramethylene-2,2‘-bipyridinium (DQ2+) entrapped in the Nafion membranes is used as an electron relay. Luminescence quenching studies indicate that the quenching reaction of Ru(bpy)32+ with DQ2+ is both of dynamic and static nature. Ru(bpy)33+ generated from the luminescence quenching remains in the Nafion matrix, while DQ+• migrates to the Nafion−water interface by an electron hopping mechanism, which transfers an electron to PVS° to produce PVS-•. The negatively charged PVS-• is repelled into the bulk solution by the anionic Nafion surface. The isolation of the photoinduced oxidized species Ru(bpy)33+ in Nafion from the ultimate reduced species PVS-• in solution prevents them from undergoing back electron transfer, a...

The photoinduced electron transfer from the excited state of cyclometallated platinum(II) complex PtL1L2 2+ (L1=4-methoxyphenyl-6-phenyl-2,2′-bibyridine, L2=pyridine) incorporated into Nafion membranes to Fe(CN)6 3− in the surrounding solution has been examined. N,N′-tetramethylene-2,2′-bipyridinium (DQ2+) entrapped in the Nafion membranes is used as an electron relay. Luminescence quenching studies indicate that the quenching reaction of the excited PtL1L2 2+ with DQ2+ is static in nature. PtL1L2 3+ generated from the luminescence quenching remains in the Nafion matrix, while DQ+ migrates by an electron hopping mechanism to the Nafion-water interface, where transfers an electron to Fe(CN)6 3− to produce Fe(CN)6 4−. The negatively charged Fe(CN)6 4− is repelled into the bulk solution by the anionic Nafion surface. The isolation of the photoinduced oxidized species PtL1L2 3+ in Nafion from the ultimate reduced species Fe(CN)6 4− in solution prevents them from undergoing back electron transfer. Thus, an extremely long-lived charge separation state is achieved in a high quantum yield.

Molecular-sieve zeolites, Nafion membranes, low-density polyethylene films, and mixed surfactant vesicles have been used as microreactors to carry out organic photochemical reactions. The photo-cycloadditions of diaryl compounds with long flexible chains included in NaY zeolite or low-density polyethylene films yield intramolecular photocyclomers to the exclusion of intermolecular products. The photosensitized oxidation of alkenes included in pentasil zeolites or Nafion membranes or vesicles can be directed selectively toward either the singlet oxygen-mediated or the superoxide radical anion-mediated products by controlling the status and location of the substrate and sensitizer molecules in the reaction media. The photo-Fries rearrangement of phenyl phenylacetates included within NaY and pentasil zeolites or Nafion membranes gives either ortho-hydroxyphenones or decarbonylation products depending on the size/shape of the microreactors and the substrate molecules. All these results demonstrate the utility of microreactors to control the product selectivity in organic photochemical reactions.

It has been reported that nonmitochondrial NAD(P)H oxidases make an important contribution to intracellular O2−· in vascular tissues and, thereby, the regulation of vascular function. Topological analyses have suggested that a well-known membrane-associated NAD(P)H oxidase may not release O2−· into the cytosol. It is imperative to clarify the source of intracellular O2−· associated with this enzyme and its physiological significance in vascular cells. The present study hypothesized that an NAD(P)H oxidase on the sarcoplasmic reticulum (SR) in coronary artery smooth muscle (CASM) regulates SR ryanodine receptor (RyR) activity by producing O2−· locally. Western blot analysis was used to detect NAD(P)H oxidase subunits in purified SR from CASM. Fluorescent spectrometric analysis demonstrated that incubation of SR with NADH time dependently produced O2−·, which could be substantially blocked by the specific NAD(P)H oxidase inhibitors diphenylene iodonium and apocynin and by SOD or its mimetic tiron. This SR NAD(P)H oxidase activity was also confirmed by HPLC analysis of conversion of NADH to NAD+. In experiments of lipid bilayer channel reconstitution, addition of NADH to the cis solution significantly increased the activity of RyR/Ca2+release channels from these SR preparations from CASM, with a maximal increase in channel open probability from 0.0044 ± 0.0005 to 0.0213 ± 0.0018; this effect of NADH was markedly blocked in the presence of SOD or tiron or the NAD(P)H oxidase inhibitors diphenylene iodonium, N-vanillylnonanamide, and apocynin. These results suggest that a local NAD(P)H oxidase system on SR from CASM regulates RyR/Ca2+channel activity and Ca2+release from SR by producing O2−·.